Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
J Neurooncol ; 118(1): 83-92, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24668609

RESUMO

About one half of malignant peripheral nerve sheath tumors (MPNST) have Neurofibromin 1 (NF1) mutations. NF1 is a tumor suppressor gene essential for negative regulation of RAS signaling. Survival for MPNST patients is poor and we sought to identify an effective combination therapy. Starting with the mTOR inhibitors rapamycin and everolimus, we screened for synergy in 542 FDA approved compounds using MPNST cells with a native NF1 loss in both alleles. We further analyzed the cell cycle and signal transduction. In vivo growth effects of the drug combination with local radiation therapy (RT) were assessed in MPNST xenografts. The synergistic combination of mTOR inhibitors with bortezomib yielded a reduction in MPNST cell proliferation. The combination of mTOR inhibitors and bortezomib also enhanced the anti-proliferative effect of radiation in vitro. In vivo, the combination of mTOR inhibitor (everolimus) and bortezomib with RT decreased tumor growth and proliferation, and augmented apoptosis. The combination of approved mTOR and proteasome inhibitors with radiation showed a significant reduction of tumor growth in an animal model and should be investigated and optimized further for MPNST therapy.


Assuntos
Neurilemoma/tratamento farmacológico , Neurilemoma/radioterapia , Neoplasias do Sistema Nervoso Periférico/tratamento farmacológico , Neoplasias do Sistema Nervoso Periférico/radioterapia , Inibidores de Proteassoma/uso terapêutico , Serina-Treonina Quinases TOR/metabolismo , Antineoplásicos/farmacologia , Caspase 3/metabolismo , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/efeitos da radiação , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Neurilemoma/patologia , Peptídeos/farmacologia , Neoplasias do Sistema Nervoso Periférico/patologia , Complexo de Endopeptidases do Proteassoma , Inibidores de Proteassoma/farmacologia , RNA Interferente Pequeno/farmacologia , Radiação Ionizante , Sirolimo/farmacologia , Serina-Treonina Quinases TOR/genética , Transfecção , Ensaios Antitumorais Modelo de Xenoenxerto
2.
J Bacteriol ; 185(3): 1018-26, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12533478

RESUMO

Xylella fastidiosa is a xylem-dwelling, insect-transmitted, gamma-proteobacterium that causes diseases in many plants, including grapevine, citrus, periwinkle, almond, oleander, and coffee. X. fastidiosa has an unusually broad host range, has an extensive geographical distribution throughout the American continent, and induces diverse disease phenotypes. Previous molecular analyses indicated three distinct groups of X. fastidiosa isolates that were expected to be genetically divergent. Here we report the genome sequence of X. fastidiosa (Temecula strain), isolated from a naturally infected grapevine with Pierce's disease (PD) in a wine-grape-growing region of California. Comparative analyses with a previously sequenced X. fastidiosa strain responsible for citrus variegated chlorosis (CVC) revealed that 98% of the PD X. fastidiosa Temecula genes are shared with the CVC X. fastidiosa strain 9a5c genes. Furthermore, the average amino acid identity of the open reading frames in the strains is 95.7%. Genomic differences are limited to phage-associated chromosomal rearrangements and deletions that also account for the strain-specific genes present in each genome. Genomic islands, one in each genome, were identified, and their presence in other X. fastidiosa strains was analyzed. We conclude that these two organisms have identical metabolic functions and are likely to use a common set of genes in plant colonization and pathogenesis, permitting convergence of functional genomic strategies.


Assuntos
Citrus/microbiologia , Gammaproteobacteria/genética , Genoma Bacteriano , Doenças das Plantas/microbiologia , Sequência de Bases , Dados de Sequência Molecular
3.
Nature ; 406(6792): 151-9, 2000 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-10910347

RESUMO

Xylella fastidiosa is a fastidious, xylem-limited bacterium that causes a range of economically important plant diseases. Here we report the complete genome sequence of X. fastidiosa clone 9a5c, which causes citrus variegated chlorosis--a serious disease of orange trees. The genome comprises a 52.7% GC-rich 2,679,305-base-pair (bp) circular chromosome and two plasmids of 51,158 bp and 1,285 bp. We can assign putative functions to 47% of the 2,904 predicted coding regions. Efficient metabolic functions are predicted, with sugars as the principal energy and carbon source, supporting existence in the nutrient-poor xylem sap. The mechanisms associated with pathogenicity and virulence involve toxins, antibiotics and ion sequestration systems, as well as bacterium-bacterium and bacterium-host interactions mediated by a range of proteins. Orthologues of some of these proteins have only been identified in animal and human pathogens; their presence in X. fastidiosa indicates that the molecular basis for bacterial pathogenicity is both conserved and independent of host. At least 83 genes are bacteriophage-derived and include virulence-associated genes from other bacteria, providing direct evidence of phage-mediated horizontal gene transfer.


Assuntos
Genoma Bacteriano , Plantas/microbiologia , Pseudomonadaceae/genética , Análise de Sequência de DNA , Aderência Bacteriana , Proteínas de Bactérias/metabolismo , Transporte Biológico , Mapeamento Cromossômico , Citrus/microbiologia , Reparo do DNA , DNA Bacteriano , Metabolismo Energético , Dados de Sequência Molecular , Plantas Tóxicas , Biossíntese de Proteínas , Pseudomonadaceae/metabolismo , Pseudomonadaceae/patogenicidade , Nicotiana/microbiologia , Transcrição Gênica , Virulência/genética
4.
Proc Natl Acad Sci U S A ; 97(7): 3491-6, 2000 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-10737800

RESUMO

Theoretical considerations predict that amplification of expressed gene transcripts by reverse transcription-PCR using arbitrarily chosen primers will result in the preferential amplification of the central portion of the transcript. Systematic, high-throughput sequencing of such products would result in an expressed sequence tag (EST) database consisting of central, generally coding regions of expressed genes. Such a database would add significant value to existing public EST databases, which consist mostly of sequences derived from the extremities of cDNAs, and facilitate the construction of contigs of transcript sequences. We tested our predictions, creating a database of 10,000 sequences from human breast tumors. The data confirmed the central distribution of the sequences, the significant normalization of the sequence population, the frequent extension of contigs composed of existing human ESTs, and the identification of a series of potentially important homologues of known genes. This approach should make a significant contribution to the early identification of important human genes, the deciphering of the draft human genome sequence currently being compiled, and the shotgun sequencing of the human transcriptome.


Assuntos
Transcrição Gênica , Animais , Neoplasias da Mama/genética , DNA Complementar , Bases de Dados Factuais , Etiquetas de Sequências Expressas , Humanos , Dados de Sequência Molecular , Fases de Leitura Aberta , Reação em Cadeia da Polimerase Via Transcriptase Reversa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...